For most women of reproductive age, assessing menstrual health and fertility usually involves regular visits to a gynecologist or another clinician. While these exams provide critical information on an individual's reproductive health status, they typically rely on personal memory, and the results are rarely, if ever, assessed at the population level. In recent years, mobile apps for menstrual tracking have become very popular, allowing us to evaluate the accuracy, reliability and tracking frequency of millions of self-observations, thereby providing an unparalleled view, both in detail and scale, on menstrual health and its evolution. We acquired self-observation data from two mobile apps dedicated to the application of the sympto-thermal fertility awareness method, resulting in a dataset of more than 30 million days of observations from over 2.7 million cycles, where up to 40% of the cycles in which users were seeking pregnancy had recordings every single day. We used a statistical and modeling approach to describe the collected data and investigate ovulation timing. We found that only 24% of ovulations occur at days 14 to 15, that ~20% of luteal phases last for only 10 days or shorter, and that pre-menstrual light bleeding is associated with earlier temperature drop in the late luteal phase. The digital epidemiology approach presented here can help to lead to a better understanding of menstrual health and its connection to women's health overall, which has historically been severely understudied.
Main Text:
A broad diversity of fertility awareness methods (FAMs) has been developed in the past century (1, 2), primarily designed to help couples manage fertility and family planning. Modern methods developed in the last quarter of the 20 th century take advantage of the precise description of menstrual variation of the basal body temperature (BBT) or waking temperature, cervical mucus quality and quantity, vaginal sensation, and cervical position (3) (4) (5) (6) . These methods have defined a set of rules that allows the identification of the fertile window around ovulation, so that couples can adapt their sexual behavior according to their reproductive objectives (7) (8) (9) . The symptothermal method, which combines BBT and cervical mucus observations, is arguably amongst the most reliable FAM for family planning (1, 2, 4, 10) . Recently, a number of mobile apps have been developed by private organizations to facilitate FAM tracking. Some of these apps provide their users with automatized interpretation with regard to the opening and closing of the fertility window (11) . Over the past few years, an increasing number of women, estimated at over 200 million (12) , have started using these apps, contributing to the accumulation of menstrual-related data from a diverse population of users at different stage of life ( Fig. 1A ).
We were interested in evaluating the potential of the collected data for the assessment of menstrual health, both at the individual level and at the population level, and to help enable better clinical-decision-making processes. We obtained two representative datasets from the apps Kindara (K) and Sympto (S) (11) ( Fig. S1A,B , Table S1 ). Both apps offer similar FAM tracking options but differ in their design and user experience ( Fig. S1AB , Table S2 ). Some of the key differences are (i) the automatic-(S) vs user-(K) interpretation of observations, (ii) the per-cycle (S) vs per-user (K) definition of fertility goals users wish to achieve, (iii) the criteria for the onset of a new cycle, i.e. fresh bleeding after ovulation (S) vs self-assessed or automatic (K), and (iv) the precision at which users can report their observations (SI).
We investigated the differences in typical use and tracking behavior of regular FAM users during their usual cycles, which we refer to as "standard cycles" (Methods). For an idealized ~28-day cycle, FAM-relevant body signs need to be recorded for 8-12 days of each cycle, i.e. a tracking frequency of ~ 43%. We found, however, that most regular users report their observations for over 16 days per cycle. For cycles in which users choose to record sexual intercourse (65% (S) -75% (K) of standard cycles), tracking frequency is increased, with over 40% of cycles being tracked every single day when seeking pregnancy ( Fig. 1B, S1D ), sometimes for long intervals (Fig. 1C ).
Confident that users regularly logged observations ( Fig. 1B) during standard cycles, we sought to characterize general patterns in the observations and frequency of the different FAM body signs. As cycle durations vary by several days, as illustrated in Fig. 2A , and given that the duration of the luteal phase (after ovulation) has been shown to vary less than the follicular phase (before ovulation) (13, 14) , we chose to show the ovulation-related observations (BBT, mucus, cervix, vaginal sensation) from the end of each cycle ( Fig. 2B -D, S2). Consistently with previous observations on a cohort of much smaller size (15) , we observed a clear shift of about 0.36°C/0.7°F in BBT between the mid-follicular phase and the mid-luteal phase ( Fig 2B, S2A ).
BBT showed a decrease at the end of the cycle, as light bleeding or spotting was reported ( Fig.   2BC ).
In an ovulatory cycle, it is well established that cervical mucus is produced in higher quantity and with a higher stretchiness in the days leading up to ovulation (5, 6, 9, 16) , which seems to be observed by users tracking their cervical mucus (85-90% (S) and 40-45% (K) of cycles) ( Fig. 2D ).
Previous studies have shown that the combination of BBT and cervical mucus variations were reliable, although not perfect, proxies for the detection of ovulation (8, (16) (17) (18) . We therefore decided to define a mathematical framework (HMM) to derive an estimate of the most likely day of ovulation with reliability indicators to reflect the uncertainty of conflicting or unexpected observation patterns (Fig. 3A , S3-5, Methods).
Based on these estimations, we could compare the distribution of cycle length to those of estimated day of ovulation and of luteal phase duration ( Fig. 3B ) for cycles with reliable ovulation estimation (109,161 cycles, Methods). We observed an asymmetrical distribution of cycle length around the typical 27 to 28 days, with a heavy tail on longer cycles. We found a similar asymmetrical distribution for follicular phase duration (or ovulation day), with a median value of 16 days, and 90% of ovulations occurring between day 10 and day 24. Only ~24% of ovulations occurred on days 14 to 15 of the cycle.
Luteal phase duration also displayed an asymmetrical distribution, but with a skew for smaller values and presenting a smaller standard deviation ( Fig. 2BC, S4B) . Median values were 12 (K) and 13 (S) days, which is in line with a previous study that used fertility monitors (19) but shorter than values reported in studies that used LH peak for timing of ovulation (14, 20) . About 35% of cycles have a luteal phase duration of 12 to 13 days, while ~20% of cycles had a luteal phase duration smaller than or equal to 10 days, which represents a higher proportion than reported in a previous epidemiological study (14) . We also observed differences between the distributions obtained from the two different apps. These differences might be due to biases found in the user population, especially for users seeking pregnancy that could be at higher risk of sub-fertility if we assume they start tracking after they have already tried to get pregnant for several months (Fig S4C) .
Intrigued by the temporal profile of BBT in the late luteal phase (Fig. 2B) , and because we observed many cases in which early temperature drops were concomitant with pre-menstrual bleeding such as illustrated in Fig. 4A , we further investigated the variations in the timing of the end-of-cycle temperature drop and of pre-menstrual bleeding. We defined 4 categories of cycles based on the intensity of pre-menstrual bleeding, including a "no bleeding reported" category.
We found that the greater the pre-menstrual bleeding, the earlier the temperature drop and the lower the temperature in the mid/late-luteal phase (Fig. 4B , significantly different BBT distributions, t-test, p < 0.05). These observations are consistent with the findings that BBT is positively regulated by progesterone and negatively by estrogen (21) . Decreasing BBT would thus reflect decreasing progesterone levels, which is critical for the timing of endometrial shedding (i.e., the menses). Prospective studies on selected cohorts with appropriate follow-up and information provided to users will provide higher quality data, which could then be used for comparison.
Based on the current findings, we suggest that self-tracking of FAM-related body signs provides an affordable means to evaluate the status and evolution of menstrual health. These long term and yet very precise recordings support the idea that the menstrual cycle, like other biological rhythms, is a vital sign whose variations inform about overall health status (22, 23) .
The digital epidemiology approach (24), where patients collect data themselves through digital means, can in this context represent a powerful method to investigate menstrual health and its connection to women's health at the population level (25) in a field that has historically been severely understudied (26) . We believe that users of such applications probably already have an increased awareness of their cycles, and this study shows that these digitally self-tracked observations present an unprecedented opportunity to facilitate the dialog between patients and their clinicians, helping them to make informed decisions based on quantified indicators. The current and future development of evidence-based digital tools for menstrual health monitoring could positively impact women's health, particularly in areas where access to healthcare is limited.
Methods
Extended Materials and Methods can be found in the Supplementary Information (SI).
Data acquisition
We obtained two de-identified datasets from the Symptotherm foundation (www.sympto.org) and Kindara (www.kindara.com) upon receiving ethical approval from the Canton Geneva -the uncertainty on the ovulation estimation was lower than ±1.5 day (SI).
-the confidence score, which is related to acceptable amount of missing data in the ovulatory period, was equal or higher than 75% (SI).
Observations decoding and ovulation timing estimation with HMM
The FAM body-signs are considered to reflect the hormonal changes orchestrating the menstrual cycles. We were interested in understanding which cycles were reported with observations that were consistent with previous literature description and for which it was thus possible to estimate timing of ovulation. Hidden Markov Models (HMM) are one of the most suitable mathematical frameworks due to its ability to uncover, from observations, latent phenomenon, which are here the cascade of hormonal events across the menstrual cycle. Briefly, we defined a 10-states HMM, in which each state is a particular phase of the menstrual cycle ( Fig. 3A top, S3A , SI), and used decoding algorithms (Viterbi -Backward-Forward) to estimate the ovulation time, the uncertainty on this estimation, and a confidence score that accounts for missing observation and variation in temperature taking times.
We then established a set of stringent criteria on the uncertainty of the ovulation estimation (≤ ±1.5 days), the magnitude of the temperature shift (≥ 0.15 C) and the confidence score of the observations (≥ 0.75) to discriminate between cycles for which the estimations could be trusted (cycles with reliable ovulation estimation) and those where the observations did not allow for a reliable estimation of the ovulation day (Fig S4A, SI) . These strict criteria lead to the exclusion of ~40% (Sympto) and ~ 89% (Kindara) of the standard cycles that were initially selected. In total, 28,453 (Sympto) + 80,708 (Kindara) cycles with reliable ovulation estimation have been used for the subsequent analyses (SI).
Model description
The Hidden Markov Model (HMM) we defined describes a discretization in 10 states of the successive hormonal events throughout an ovulatory menstrual cycle. The HMM definition also includes the probabilities of observing the different FAM reported body signs in each state (emission probabilities) and the probabilities of switching from one state to another (transition probabilities). Emission probabilities were chosen to reflect observations previously made in studies that tested for ovulation with LH tests or ultrasounds (6, 8, 16) , while transition probabilities were chosen in a quasi-uniform manner (SI). We found that the ovulation estimations were robust to changes in transition probabilities but not to variations in emission probabilities (Fig S5, SI) , indicating that this simple framework is suitable to detect ovulations in cycles of any length, and potentially including pregnancies, relying primarily on users'
observations.
Once the model was defined, we used the Viterbi and the Backward-Forward algorithms (27) to calculate the most probable state sequence for each cycle (SI) and thus to have an estimation of ovulation timing, i.e. the most likely day of the cycle in which the HMM is in the state "ovulation". We also computed the uncertainty of the estimation, i.e. the standard deviation of the distribution of probabilities for the state 'ovulation', which can be interpreted as the confidence interval in days for the time of ovulation estimation (SI). We also defined a confidence score that accounts for missing observations and variation in temperature taking time in a window of ~5 days around the estimated ovulation day (SI).
HMM states
We defined 10 states as a discretization of the hormonal evolution across the cycle (further 
